Decision Diagnostics Corp (DECN)

[Raffis]

DECN CREATED THE ONLY MULTI-VIRAL DETECTION TEST WITH A PATENTED “TBG SYSTEM,” THAT ELIMINATES THE NEED TO LYSE BLOOD HEMATOCRIT FOR VIRAL ISOLATION AND DETECTION. OUR TEST DOES NOT REQUIRE ANY LYSIS BUFFER, OR SURFACTANT AGENT AND COMPLETELY ELIMINATES HEMATOCRIT CROSS REACTIVITY WITH THE TBG-ADJUSTMENT FEATURE. THE GENVIRO SWIFT INCORPORATES THE
“TBG”TECHNOLOGY THAT ELIMINATES HEMATOCRIT INTERFERENCE. AND THE GENVIRO PROVIDES ACCURATE DIAGNOSTIC, LAB QUALITY RESULTS THAT ARE COMPARABLE TO EXISTING, SLOWER AND MORE COSTLY VIROLOGICAL LAB TESTS. OUR VIROLOGICAL DETECTION TEST PROVIDES RESULTS IN 10.5 SECONDS. OUR TEST PRODUCES THE FASTEST VIRUS DETECTION RESULTS IN THE WORLD.

IN ADDITION TO THE EMBEDDED TBG-TECHNOLOGY, DECN ALSO COMBINED THE MULTI-FUNCTIONALITY OF DETECTING VIRUSES THROUGH SALIVA, OR BLOOD IN THE SAME STATE OF THE ART TEST METER AND MULTI-FUNCTIONAL, PATENTED TEST STRIPS. DECN IS THE ONLY COMPANY IN THE WORLD THAT OFFERS THIS MULTI-FUNCTIONAL, VIRUS DETECTING TECHNOLOGY THAT MEETS AND SATISFIES THE USFDA REQUIREMENTS FOR IN VITRO VIRUS DETECTION PROTOCOLS AND CGMP REQUIREMENTS OF EUROPEAN CE MARKING.